应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
02607 上海医药
未开盘 02-18 16:08:13
12.340
+0.100
+0.82%
最高
12.400
最低
12.160
成交量
418.93万
今开
12.180
昨收
12.240
日振幅
1.96%
总市值
457.57亿
流通市值
113.40亿
总股本
37.08亿
成交额
5,153万
换手率
0.46%
流通股本
9.19亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
每周股票复盘：上海医药（601607）2019年A股股票期权激励计划预留股票期权行权受限
证券之星 · 02-15
每周股票复盘：上海医药（601607）2019年A股股票期权激励计划预留股票期权行权受限
上药控股与领先仿生战略合作 围绕人工耳蜗业务展开合作
美港电讯 · 02-14
上药控股与领先仿生战略合作 围绕人工耳蜗业务展开合作
上海医药（601607）2月10日主力资金净买入1926.13万元
证券之星 · 02-11
上海医药（601607）2月10日主力资金净买入1926.13万元
上证上海改革发展主题指数上涨1.64%，前十大权重包含上海医药等
金融界 · 02-07
上证上海改革发展主题指数上涨1.64%，前十大权重包含上海医药等
上海医药(02607.HK)：细胞疗法研究成果再获国际学术关注
阿斯达克财经 · 02-07
上海医药(02607.HK)：细胞疗法研究成果再获国际学术关注
【上海医药：细胞疗法研究成果再获国际学术关注】 据上海医药消息，当地时间2025年2月4日，美国临床肿瘤学会专业学报报道了上海医药集团旗下上药生物治疗有限公司、上海医药集团生物治疗技术有限公司与上海儿童医学中心共同研发的针对儿童白血病的细胞疗法研究成果。这是继该研究成果亮相第66届美国血液学会年会后再一次被业内权威平台关注。
金融界 · 02-07
【上海医药：细胞疗法研究成果再获国际学术关注】 据上海医药消息，当地时间2025年2月4日，美国临床肿瘤学会专业学报报道了上海医药集团旗下上药生物治疗有限公司、上海医药集团生物治疗技术有限公司与上海儿童医学中心共同研发的针对儿童白血病的细胞疗法研究成果。这是继该研究成果亮相第66届美国血液学会年会后再一次被业内权威平台关注。
上海医药02月03日主力资金流入98万元 连续3日加仓
市场透视 · 02-03
上海医药02月03日主力资金流入98万元 连续3日加仓
智通港股早知道 | 郁亮辞任万科(02202)董事会主席 深铁集团董事长辛杰接任
智通财经 · 01-28
智通港股早知道 | 郁亮辞任万科(02202)董事会主席 深铁集团董事长辛杰接任
港股公告掘金 | 基石药业-B与SteinCares就舒格利单抗在拉丁美洲地区达成战略合作
智通财经 · 01-27
港股公告掘金 | 基石药业-B与SteinCares就舒格利单抗在拉丁美洲地区达成战略合作
上海生物医药并购基金首关落地 上海医药、东富龙等多家“链主”参与
澎湃新闻 · 01-27
上海生物医药并购基金首关落地 上海医药、东富龙等多家“链主”参与
上海医药(02607.HK)拟参与设立生物医药并购基金
格隆汇 · 01-27
上海医药(02607.HK)拟参与设立生物医药并购基金
上海医药最新公告：拟10亿元参与设立上海生物医药并购基金
证券之星 · 01-27
上海医药最新公告：拟10亿元参与设立上海生物医药并购基金
上海医药(601607.SH)拟斥10亿元参设上海生物医药并购股权投资合伙企业
智通财经 · 01-27
上海医药(601607.SH)拟斥10亿元参设上海生物医药并购股权投资合伙企业
海通国际：维持上海医药(02607)“优于大市”评级 目标价上调至14.39港元
智通财经 · 01-24
海通国际：维持上海医药(02607)“优于大市”评级 目标价上调至14.39港元
【券商聚焦】海通国际维持上海医药(02607)优于大市评级 料2024全年营收同比增6.5%
金吾财讯 · 01-24
【券商聚焦】海通国际维持上海医药(02607)优于大市评级 料2024全年营收同比增6.5%
金十数据整理：每日港股市场要闻速递（1月23日 周四）
美港电讯 · 01-23
金十数据整理：每日港股市场要闻速递（1月23日 周四）
上海医药(2607.HK)2024年业绩前瞻：医药商业稳定增长；降本增效持续推进
海通国际 · 01-23
上海医药(2607.HK)2024年业绩前瞻：医药商业稳定增长；降本增效持续推进
上海医药(02607)：常州制药厂的熊去氧胆酸胶囊获得批准生产
智通财经 · 01-22
上海医药(02607)：常州制药厂的熊去氧胆酸胶囊获得批准生产
上海医药：熊去氧胆酸胶囊获批准生产
国际金融报 · 01-22
上海医药：熊去氧胆酸胶囊获批准生产
上海医药：控股子公司熊去氧胆酸胶囊获得批准生产
每日经济新闻 · 01-22
上海医药：控股子公司熊去氧胆酸胶囊获得批准生产
加载更多
公司概况
公司名称：
上海医药
所属市场：
SEHK
上市日期：
--
主营业务：
上海医药集团股份有限公司是一家主要从事医药工业、分销与零售业务的中国公司。该公司的产品包括创新药、化学药、中药和罕见病药。该公司的产品主要用于心血管系统、消化道和新陈代谢、全身性抗感染、中枢神经系统、抗肿瘤和免疫调节剂、骨骼肌肉系统和呼吸系统等领域。另外，该公司还提供医药物流和仓储服务。该公司的产品销往中国国内和海外市场。
发行价格：
--
{"stockData":{"symbol":"02607","market":"HK","secType":"STK","nameCN":"上海医药","latestPrice":12.34,"timestamp":1739866093016,"preClose":12.24,"halted":0,"volume":4189282,"delay":0,"floatShares":919000000,"shares":3708000000,"eps":1.0877061689924048,"marketStatus":"未开盘","change":0.1,"latestTime":"02-18 16:08:13","open":12.18,"high":12.4,"low":12.16,"amount":51534965,"amplitude":0.019608,"askPrice":12.34,"askSize":53700,"bidPrice":12.32,"bidSize":9100,"shortable":3,"etf":0,"ttmEps":1.1542353795837772,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1739928600000},"marketStatusCode":0,"adr":0,"listingDate":1305820800000,"exchange":"SEHK","adjPreClose":12.24,"dividendRate":0.04295,"openAndCloseTimeList":[[1739842200000,1739851200000],[1739854800000,1739865600000]],"volumeRatio":0.847154,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"601607","market":"SH","secType":"STK","nameCN":"上海医药","latestPrice":19.82,"timestamp":1739862000000,"preClose":20.03,"halted":0,"volume":8454100,"delay":0,"premium":"-41.73"}},"requestUrl":"/m/hq/s/02607","defaultTab":"news","newsList":[{"id":"2511644783","title":"每周股票复盘：上海医药（601607）2019年A股股票期权激励计划预留股票期权行权受限","url":"https://stock-news.laohu8.com/highlight/detail?id=2511644783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511644783?lang=zh_cn&edition=full","pubTime":"2025-02-15 08:45","pubTimestamp":1739580309,"startTime":"0","endTime":"0","summary":"截至2025年2月14日收盘，上海医药报收于20.2元，较上周的20.31元下跌0.54%。本周，上海医药2月10日盘中最高价报20.36元。本周关注点公司公告汇总: 上海医药集团股份有限公司发布关于2019年A股股票期权激励计划预留股票期权第三个行权期限制行权期间的提示性公告公司公告汇总上海医药集团股份有限公司发布了关于2019年A股股票期权激励计划预留股票期权第三个行权期限制行权期间的提示性公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021500011359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0184","BK0196","601607","BK0020","BK0209","02607","BK0188","BK1197","159982","BK0028","BK0012","BK0187","399300","BK0099","BK0175","BK0183"],"gpt_icon":0},{"id":"2511005715","title":"上药控股与领先仿生战略合作 围绕人工耳蜗业务展开合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2511005715","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511005715?lang=zh_cn&edition=full","pubTime":"2025-02-14 09:02","pubTimestamp":1739494975,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0188","BK0012","BK0183","BK1197","BK0196","BK0209","02607","BK0187","601607","BK0097","BK0099","BK0175","BK0028","BK0184","BK0020"],"gpt_icon":0},{"id":"2510784821","title":"上海医药（601607）2月10日主力资金净买入1926.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510784821","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510784821?lang=zh_cn&edition=full","pubTime":"2025-02-11 08:51","pubTimestamp":1739235080,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年2月10日收盘，上海医药报收于20.16元，下跌0.74%，换手率0.65%，成交量12.62万手，成交额2.54亿元。近5日资金流向一览见下表：上海医药融资融券信息显示，融资方面，当日融资买入1837.49万元，融资偿还1192.75万元，融资净买入644.74万元，连续3日净买入累计3195.25万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021100006478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0183","BK0184","BK0028","BK0187","BK0097","BK0209","02607","BK0020","BK1197","BK0188","BK0196","601607","BK0099","BK0175"],"gpt_icon":0},{"id":"2509749761","title":"上证上海改革发展主题指数上涨1.64%，前十大权重包含上海医药等","url":"https://stock-news.laohu8.com/highlight/detail?id=2509749761","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509749761?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:08","pubTimestamp":1738937314,"startTime":"0","endTime":"0","summary":"数据统计显示，上证上海改革发展主题指数近一个月上涨0.46%，近三个月下跌8.66%，年至今下跌5.56%。从上证上海改革发展主题指数持仓的市场板块来看，上海证券交易所占比100.00%。从上证上海改革发展主题指数持仓样本的行业来看，工业占比31.57%、金融占比19.11%、可选消费占比17.79%、房地产占比11.90%、通信服务占比4.91%、医药卫生占比4.81%、信息技术占比4.06%、公用事业占比2.71%、原材料占比1.64%、主要消费占比1.50%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/07220848030464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159982","02607","BK1197","BK0020","510820","BK0097","BK0184","BK0196","601607","BK0187","BK0012","000001.SH","BK0183","BK0175","399300","BK0028","BK0209","BK0099","BK0188"],"gpt_icon":0},{"id":"2509758305","title":"上海医药(02607.HK)：细胞疗法研究成果再获国际学术关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2509758305","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509758305?lang=zh_cn&edition=full","pubTime":"2025-02-07 09:43","pubTimestamp":1738892580,"startTime":"0","endTime":"0","summary":"上海医药(02607.HK) (601607.SH) 表示，美国临床肿瘤学会专业学报(THE ASCO POST)日前报道上海医药集团旗下上药生物治疗(香港)及上海医药集团生物治疗技术，与上海儿童医学中心共同研发的针对儿童白血病的细胞疗法研究成果。这是继该研究成果亮相第66届美国血液学会(ASH)年会后再一次被业内权威平台关注。(ta/k) (港股报价延迟最少十五分钟。沽空资料截至 2025-02-06 16:25。) (A股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180202161553962_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180202161553962_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1415498/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02607","BK0020","BK0097","BK0099","BK0012","BK0188","BK0175","BK0196","601607","BK0209","BK0183","BK0184","BK0028","BK0187","BK1197"],"gpt_icon":0},{"id":"2509374977","title":"【上海医药：细胞疗法研究成果再获国际学术关注】 据上海医药消息，当地时间2025年2月4日，美国临床肿瘤学会专业学报报道了上海医药集团旗下上药生物治疗有限公司、上海医药集团生物治疗技术有限公司与上海儿童医学中心共同研发的针对儿童白血病的细胞疗法研究成果。这是继该研究成果亮相第66届美国血液学会年会后再一次被业内权威平台关注。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509374977","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509374977?lang=zh_cn&edition=full","pubTime":"2025-02-07 09:29","pubTimestamp":1738891789,"startTime":"0","endTime":"0","summary":"据上海医药消息，当地时间2025年2月4日，美国临床肿瘤学会专业学报报道了上海医药集团旗下上药生物治疗有限公司、上海医药集团生物治疗技术有限公司与上海儿童医学中心共同研发的针对儿童白血病的细胞疗法研究成果。这是继该研究成果亮相第66届美国血液学会年会后再一次被业内权威平台关注。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/07092948005874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0099","BK0184","BK1197","02607","BK0209","BK0097","BK0020","BK0028","BK0012","BK0183","BK0187","BK0188","BK0196","601607","BK0175"],"gpt_icon":0},{"id":"2508197694","title":"上海医药02月03日主力资金流入98万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2508197694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508197694?lang=zh_cn&edition=full","pubTime":"2025-02-03 16:17","pubTimestamp":1738570624,"startTime":"0","endTime":"0","summary":"02月03日, 上海医药股价跌1.13%，报收12.22元，成交金额1719万元，换手率0.15%，振幅2.10%，量比0.64。上海医药今日主力资金净流入98万元，连续3日净流入，上一交易日主力净流入368万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为55.00%，平均涨幅为1.19%。该股近5个交易日下跌1.14%，主力资金累计净流出23万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入284万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203161719a237c082&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203161719a237c082&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02607","BK1197"],"gpt_icon":0},{"id":"2506534675","title":"智通港股早知道 | 郁亮辞任万科(02202)董事会主席 深铁集团董事长辛杰接任","url":"https://stock-news.laohu8.com/highlight/detail?id=2506534675","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506534675?lang=zh_cn&edition=full","pubTime":"2025-01-28 07:51","pubTimestamp":1738021909,"startTime":"0","endTime":"0","summary":"深圳地铁董事长辛杰出任万科董事会主席郁亮出任万科第一执行副总裁据万科A公告，深圳地铁董事长辛杰出任万科董事会主席，而辞去董事会主席一职的郁亮则出任万科第一执行副总裁。2024年营业收入较2023年下降主要系上年同期交付大订单，本年度不再有相关订单所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3993a068a19470eb66cea72889d8f0f6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1244844.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1135","BK1113","00189","HSCEI","BK1500","BK1555","BK1521","BK1543","BK1129","HSTECH","BK1197","YANG","BK1240","02233","BK1522","00297","BK1594","BK1507","02607","000002","IE0034224299.USD","BK1511"],"gpt_icon":1},{"id":"2506305697","title":"港股公告掘金 | 基石药业-B与SteinCares就舒格利单抗在拉丁美洲地区达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2506305697","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506305697?lang=zh_cn&edition=full","pubTime":"2025-01-27 21:59","pubTimestamp":1737986375,"startTime":"0","endTime":"0","summary":"重大事项：协合新能源(00182)附属拟6.36亿元向沙电出售泰鸣公司的100%股权万科企业(02202)拟转让于红树湾项目的出售权益及出售股权上海医药(02607)拟参与设立生物医药并购基金基石药业-B(02616)与SteinCares就舒格利单抗在拉丁美洲地区达成战略合作经营业绩：中铝国际(02068)2024年新签合同总额308.26亿元普华和顺(01358)附属四川睿健医疗前三季度净利润","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1244797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1240","BK1507","IE0034224299.USD","HSCEI","YANG","BK1558","BK1521","02068","BK1154","BK1555","BK1594","BK1148","BK1574","BK1554","BK1197","02616","BK1505","BK1161","00182","000002","02607","HSTECH"],"gpt_icon":0},{"id":"2506377380","title":"上海生物医药并购基金首关落地 上海医药、东富龙等多家“链主”参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2506377380","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506377380?lang=zh_cn&edition=full","pubTime":"2025-01-27 21:34","pubTimestamp":1737984895,"startTime":"0","endTime":"0","summary":"由上实集团发起设立的上海生物医药并购基金公告首关落地。1月27日，根据上海医药（601607.SH）公告，公司拟作为有限合伙人之一参与设立上海生物医药并购股权投资合伙企业（有限合伙）（简称“上海生物医药并购基金”），拟出资金额为10亿元。公告显示，上海生物医药并购基金首期规模约50.1亿元，上海上实资本管理有限公司（简称“上实资本”）拟担任基金管理人和执行事务合伙人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202501273309447554.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202501273309447554.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1197","02607"],"gpt_icon":0},{"id":"2506329365","title":"上海医药(02607.HK)拟参与设立生物医药并购基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2506329365","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506329365?lang=zh_cn&edition=full","pubTime":"2025-01-27 17:09","pubTimestamp":1737968981,"startTime":"0","endTime":"0","summary":"格隆汇1月27日丨上海医药(02607.HK)发布公告，2025年1月27日，公司拟参与设立生物医药并购基金，其中，国投先导(作为有限合伙人)、公司(作为有限合伙人)、东富龙(作为有限合伙人)、君实生物(作为有限合伙人)、镁信健康(作为有限合伙人)、新华保险(作为有限合伙人)、工银安盛人寿(作为有限合伙人)、浦东引领区基金(作为有限合伙人)、张江科技(作为有限合伙人)、兴嘉二期(作为有限合伙人)、","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/27170947848435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0209","BK0012","BK0099","BK0188","BK0028","BK0020","BK0196","BK0187","BK0175","601607","161726","399441","BK0097","BK0183","BK0184","02607","BK1197"],"gpt_icon":0},{"id":"2506329569","title":"上海医药最新公告：拟10亿元参与设立上海生物医药并购基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2506329569","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506329569?lang=zh_cn&edition=full","pubTime":"2025-01-27 17:07","pubTimestamp":1737968875,"startTime":"0","endTime":"0","summary":"上海医药公告称，公司拟作为有限合伙人之一参与设立上海生物医药并购股权投资合伙企业（有限合伙），拟出资金额为10亿元。该基金募集资金预计50.1亿元，将由上海上实资本管理有限公司和上海生物医药并购股权投资基金管理有限公司担任普通合伙人。上海医药表示，参与设立该基金符合公司战略布局，将促进产业链集聚整合、推动产业转型升级。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012700021953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0020","BK0012","BK0188","BK0099","BK0187","601607","399441","BK0209","BK1197","BK0196","BK0183","BK0184","BK0028","02607","BK0175","161726","BK0097"],"gpt_icon":0},{"id":"2506688325","title":"上海医药(601607.SH)拟斥10亿元参设上海生物医药并购股权投资合伙企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2506688325","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506688325?lang=zh_cn&edition=full","pubTime":"2025-01-27 16:33","pubTimestamp":1737966799,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药(601607.SH)公告，公司拟作为有限合伙人之一参与设立上海生物医药并购股权投资合伙企业(有限合伙)，拟出资金额为10亿元。公告称，标的基金将成为促进产业链集聚整合、推动产业转型升级、拓宽资本退出通道的重要工具，可为上海加快打造全球生物医药研发经济和产业化高地提供重要支撑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1244536.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601607","02607","BK0187","399441","BK0028","BK1197","BK0012","BK0020","BK0097","BK0209","BK0183","BK0175","161726","BK0099","BK0184","BK0196","BK0188"],"gpt_icon":0},{"id":"2505077957","title":"海通国际：维持上海医药(02607)“优于大市”评级 目标价上调至14.39港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505077957","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505077957?lang=zh_cn&edition=full","pubTime":"2025-01-24 09:55","pubTimestamp":1737683747,"startTime":"0","endTime":"0","summary":"基于WACC6.2%、永续增长率3%、港股对A股折价60%(均不变)，对应目标价上调4.1%至14.39港元，维持公司“优于大市”评级。海通国际主要观点如下：2024年上海医药业绩前瞻：医药商业稳健增长，医药工业小幅下滑;降本增效持续推进收入端：该行预计上海医药2024年将实现营收2,773亿元，同比+6.5%。上海和黄药业2023年实现收入/净利润27/6.6亿元;2024年1-10月实现收入/净利润25/6.3亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1243117.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02607","601607"],"gpt_icon":0},{"id":"2505307902","title":"【券商聚焦】海通国际维持上海医药(02607)优于大市评级 料2024全年营收同比增6.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505307902","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505307902?lang=zh_cn&edition=full","pubTime":"2025-01-24 09:02","pubTimestamp":1737680579,"startTime":"0","endTime":"0","summary":"金吾财讯 | 海通国际发研报指，预计上海医药 2024年将实现营收2,773亿元，同比+6.5%。该行预计上海医药2024年毛利率同比下滑0.9个百分点至11.1%，主要受集采降价影响和低毛利率的分销业务占比提高影响。该行预计2024年财务费用率将基本维持在0.6%，经营利润同比增长5.9%至81亿元。该行略微下调上海医药2024年的收入预测至2,773亿元，略微上调2025/26年收入预测至3,008/3,240亿元，以反映收购和黄药业后的影响；略微下调2024/25/26年归母净利润分别至48/54/57亿元。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/YTg5NTFiOTlmZmEyYmE3ODE4NjgwNzc4MTUzMTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/YTg5NTFiOTlmZmEyYmE3ODE4NjgwNzc4MTUzMTI=.jpg"],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1952101","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601607","02607"],"gpt_icon":0},{"id":"2505081020","title":"金十数据整理：每日港股市场要闻速递（1月23日 周四）","url":"https://stock-news.laohu8.com/highlight/detail?id=2505081020","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505081020?lang=zh_cn&edition=full","pubTime":"2025-01-23 09:02","pubTimestamp":1737594165,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["00883","IE00BYQNZ168.SGD","603993","IE00BYTNYN87.SGD","BK1136","HSCEI","01133","01929","BK1593","LU0163747925.USD","BK1502","BK1238","BK1205","LU0516422952.EUR","BK1161","BK0172","BK0164","BK0096","LU0572944931.SGD","BK1601","02696","LU1997244956.HKD","HSTECH","BK0012","LU1997245094.SGD","BK0060","YANG","03993","02196","SGXZ81163826.USD","07226","601618","BK1148","600196","01618","BK1610","02601","BK1594","BK0188","601601","LU1242518857.USD","BK1545","02607","01691","BK0020","601607","80883","LU0531971595.HKD","SG9999001226.SGD","LU0164880469.USD"],"gpt_icon":0},{"id":"2505400098","title":"上海医药(2607.HK)2024年业绩前瞻：医药商业稳定增长；降本增效持续推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2505400098","media":"海通国际","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505400098?lang=zh_cn&edition=full","pubTime":"2025-01-23 00:00","pubTimestamp":1737561600,"startTime":"0","endTime":"0","summary":"2024 年上海医药业绩前瞻医药商业稳健增长，医药工业小幅下滑；降本增效持续推进收入端：我们预计上海医药2024 年将实现营收2,773 亿元，同比+6.5%。收购上海和黄药业10%股权：2024 年1 月，上海医药宣布与和黄医药签订股份转让协议，约定上海医药收购标的公司上海和黄药业10%股权，交易完成后，上海医药将合计持有上海和黄药业60%股权，成为实际控制人。上海和黄药业2023 年实现收入/净利润27/6.6 亿元；2024 年1-10 月实现收入/净利润25/6.3 亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123182644a22ccaca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123182644a22ccaca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1197","02607","BK1515","BK1574","09939"],"gpt_icon":0},{"id":"2505871593","title":"上海医药(02607)：常州制药厂的熊去氧胆酸胶囊获得批准生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2505871593","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505871593?lang=zh_cn&edition=full","pubTime":"2025-01-22 17:32","pubTimestamp":1737538353,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药 公布，近日，公司控股子公司常州制药厂有限公司的熊去氧胆酸胶囊收到国家药品监督管理局颁发的《药品注册证书》，该药品获得批准生产。2023 年 6 月常州制药厂有限公司就该药品向国家药监局提出注册上市申请，并获受理。因此常州制药厂有限公司的熊去氧胆酸胶囊获得批准生产，有利于扩大该药品的市场份额，提升市场竞争力，同时为公司后续产品开展仿制药申报积累了宝贵的经验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1241872.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0099","BK0175","BK0028","601607","BK0184","BK0097","BK0020","BK0196","BK0187","02607","BK0209","BK0012","BK0183","BK1197","BK0188"],"gpt_icon":0},{"id":"2505715442","title":"上海医药：熊去氧胆酸胶囊获批准生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2505715442","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505715442?lang=zh_cn&edition=full","pubTime":"2025-01-22 16:42","pubTimestamp":1737535339,"startTime":"0","endTime":"0","summary":"上海医药公告，上海医药集团股份有限公司的熊去氧胆酸胶囊获得国家药品监督管理局批准生产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122164708abb4442b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122164708abb4442b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02607","BK1197"],"gpt_icon":0},{"id":"2505970067","title":"上海医药：控股子公司熊去氧胆酸胶囊获得批准生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2505970067","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505970067?lang=zh_cn&edition=full","pubTime":"2025-01-22 16:34","pubTimestamp":1737534885,"startTime":"0","endTime":"0","summary":"每经AI快讯，1月22日，上海医药公告，其控股子公司常州制药厂的熊去氧胆酸胶囊（规格250mg）已收到国家药监局颁发的《药品注册证书》，获准生产。该药品主要用于治疗胆囊胆固醇结石、胆汁淤积性肝病和胆汁反流性胃炎。截至公告日，公司针对该药品已投入研发费用约1215万元。预计该药品的批准生产将有利于扩大市场份额，提升市场竞争力，并为公司后续产品开展仿制药申报积累经验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202501223304842162.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202501223304842162.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02607","BK1197"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.shaphar.com.cn","stockEarnings":[{"period":"1week","weight":0.0198},{"period":"1month","weight":0.0082},{"period":"3month","weight":-0.0595},{"period":"6month","weight":0.0917},{"period":"1year","weight":0.0338},{"period":"ytd","weight":-0.0222}],"compareEarnings":[{"period":"1week","weight":0.079},{"period":"1month","weight":0.1732},{"period":"3month","weight":0.166},{"period":"6month","weight":0.3025},{"period":"1year","weight":0.4222},{"period":"ytd","weight":0.1454}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海医药集团股份有限公司是一家主要从事医药工业、分销与零售业务的中国公司。该公司的产品包括创新药、化学药、中药和罕见病药。该公司的产品主要用于心血管系统、消化道和新陈代谢、全身性抗感染、中枢神经系统、抗肿瘤和免疫调节剂、骨骼肌肉系统和呼吸系统等领域。另外，该公司还提供医药物流和仓储服务。该公司的产品销往中国国内和海外市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.00299},{"month":2,"riseRate":0.571429,"avgChangeRate":0.020776},{"month":3,"riseRate":0.615385,"avgChangeRate":0.015455},{"month":4,"riseRate":0.538462,"avgChangeRate":0.003331},{"month":5,"riseRate":0.538462,"avgChangeRate":-0.00636},{"month":6,"riseRate":0.5,"avgChangeRate":-0.012586},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.020804},{"month":8,"riseRate":0.428571,"avgChangeRate":0.005824},{"month":9,"riseRate":0.357143,"avgChangeRate":0.015401},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.020412},{"month":11,"riseRate":0.428571,"avgChangeRate":0.031213},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.011642}],"exchange":"SEHK","name":"上海医药","nameEN":"SH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.1","shortVersion":"4.31.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"上海医药(02607)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供上海医药(02607)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"上海医药,02607,上海医药股票,上海医药股票老虎,上海医药股票老虎国际,上海医药行情,上海医药股票行情,上海医药股价,上海医药股市,上海医药股票价格,上海医药股票交易,上海医药股票购买,上海医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"上海医药(02607)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供上海医药(02607)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}